Compare
Establishment Labs Holdings Inc. vs Lakeland Industries Inc vs Inogen Inc vs Sanara MedTech Inc.
| Latest fiscal year | Establishment Labs Holdings Inc. ESTA | Lakeland Industries Inc LAKE | Inogen Inc INGN | Sanara MedTech Inc. SMTI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-01-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $211.08M | $192.65M | $348.67M | $103.12M |
| Revenue growth (YoY) | +27.1% | +15.2% | +3.9% | +19.0% |
| Gross margin | 69.3% | 32.9% | 44.2% | 92.7% |
| Operating margin | -18.5% | -8.1% | -8.7% | 7.1% |
| Net margin | -24.2% | -13.1% | -6.5% | -36.4% |
| Net income | -$51.06M | -$25.31M | -$22.75M | -$37.56M |
| EPS (Diluted) | -$1.72 | -$2.63 | -$0.86 | -$4.36 |
| Operating cash flow | -$50.89M | -$15.75M | -$11.22M | $6.79M |
| Free cash flow | -$56.94M | -$16.42M | -$13.74M | $2.16M |
| Cash & equivalents | $75.57M | n/a | $103.73M | $16.58M |
| Total assets | $357.17M | $209.93M | $298.62M | $72.94M |
| Total liabilities | $333.62M | $80.81M | $106.39M | $67.01M |
| Shareholders' equity | $23.55M | $129.13M | $192.23M | $5.94M |
| Return on year-end equity | -216.9% | -19.6% | -11.8% | -632.5% |
| Shares outstanding | 29.30M | 9.81M | 27.23M | 8.95M |
Revenue, most recent five fiscal years
| Fiscal year | Establishment Labs Holdings Inc. | Lakeland Industries Inc | Inogen Inc | Sanara MedTech Inc. |
|---|---|---|---|---|
| Latest | $211.08M Ended 2025-12-31 | $192.65M Ended 2026-01-31 | $348.67M Ended 2025-12-31 | $103.12M Ended 2025-12-31 |
| 1 year earlier | $166.03M Ended 2024-12-31 | $167.21M Ended 2025-01-31 | $335.70M Ended 2024-12-31 | $86.67M Ended 2024-12-31 |
| 2 years earlier | $165.15M Ended 2023-12-31 | $124.69M Ended 2024-01-31 | $315.66M Ended 2023-12-31 | $64.99M Ended 2023-12-31 |
| 3 years earlier | $161.70M Ended 2022-12-31 | $112.85M Ended 2023-01-31 | $377.24M Ended 2022-12-31 | $45.84M Ended 2022-12-31 |
| 4 years earlier | $126.68M Ended 2021-12-31 | $118.39M Ended 2022-01-31 | $358.00M Ended 2021-12-31 | $24.14M Ended 2021-12-31 |